Research Article

GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer

Figure 8

The difference of IC50 scores of targeted drugs in two groups (high and low) based on GLTP expressions via the ACLBI website: (a) Cisplatin, (b) Docetaxel, (c) Paclitaxel, and (d) Bleomycin. , , , and .
(a)
(b)
(c)
(d)